170 related articles for article (PubMed ID: 1691592)
1. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
[TBL] [Abstract][Full Text] [Related]
2. Variable expression of Epstein-Barr virus genome as demonstrated by in situ hybridization in central nervous system lymphomas in immunocompromised patients.
Bashir RM; Hochberg FH; Harris NL; Purtilo D
Mod Pathol; 1990 Jul; 3(4):429-34. PubMed ID: 2170968
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of immunohistochemistry and in situ hybridization techniques in diseases caused by or associated with Epstein-Barr virus].
Audouin J; Prevot S; Brouland JP; Molina T; Le Tourneau A; Diebold J
Arch Anat Cytol Pathol; 1992; 40(2-3):95-104. PubMed ID: 1333177
[TBL] [Abstract][Full Text] [Related]
4. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
6. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus.
Chang KL; Flaris N; Hickey WF; Johnson RM; Meyer JS; Weiss LM
Mod Pathol; 1993 Jul; 6(4):427-32. PubMed ID: 8415586
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
8. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.
Hamilton-Dutoit SJ; Pallesen G; Franzmann MB; Karkov J; Black F; Skinhøj P; Pedersen C
Am J Pathol; 1991 Jan; 138(1):149-63. PubMed ID: 1846263
[TBL] [Abstract][Full Text] [Related]
9. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
[TBL] [Abstract][Full Text] [Related]
10. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Pizzo PA; Chattopadhyay SK; Magrath IT; Del Giacco E; Sherrick D; Gray T
Cancer Res; 1981 Aug; 41(8):3165-71. PubMed ID: 6265077
[TBL] [Abstract][Full Text] [Related]
11. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.
Andiman W; Gradoville L; Heston L; Neydorff R; Savage ME; Kitchingman G; Shedd D; Miller G
J Infect Dis; 1983 Dec; 148(6):967-77. PubMed ID: 6317774
[TBL] [Abstract][Full Text] [Related]
12. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus.
Bacchi MM; Bacchi CE; Alvarenga M; Miranda R; Chen YY; Weiss LM
Mod Pathol; 1996 Jan; 9(1):63-7. PubMed ID: 8821959
[TBL] [Abstract][Full Text] [Related]
15. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr-virus-induced lymphoproliferative diseases].
Schuster V; Kreth HW
Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
18. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
de-Thé G
IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
